RR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.
Latest preprint reviews
-
SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventions
This article has 12 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
A prenylated dsRNA sensor protects against severe COVID-19
This article has 49 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
This article has 15 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Anti-PF4 levels of patients with VITT do not reduce 4 months following AZD1222 vaccination
This article has 9 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
This article has 302 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152
This article has 13 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Tetherin antagonism by SARS‐CoV‐2 ORF3a and spike protein enhances virus release
This article has 15 authors:Reviewed by Review Commons, Rapid Reviews Infectious Diseases, ScreenIT
-
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
This article has 16 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
This article has 29 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
This article has 31 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT